跳至主要内容
临床试验/NCT06989099
NCT06989099招募中2 期

Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial

M.D. Anderson Cancer Center1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年9月24日最近更新:
干预措施

试验速览

阶段
2 期
状态
招募中
入组人数
50
试验地点
1
主要终点
Freedom from lymphedema (FFL)

研究概览

简要总结

To learn if reconstruction of the lymphatic system at the time of axillary lymphadenectomy can reduce the risk of developing lymphedema.

详细描述

Primary Objectives

- To determine the freedom from lymphedema (FFL) rate at 2 years postoperatively in participants with a diagnosis of IBC undergoing ILR at the time of ALND.

Secondary Objectives

  • Estimate the proportion of participants who have lymphedema that persists at 2 years after ILR surgeries.
  • Determine baseline lymphatic vessel anatomical or functional characteristics associated with increased risk of lymphedema following ILR.
  • Evaluate changes in systemic inflammatory mediators and systemic immune cell function affiliated with lymphedema development.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants diagnosed with IBC.
  • Participants who have been scheduled for ILR/pLVB by their treating physician/surgeon at the time of their axillary lymphadenectomy for breast cancer
  • Participants willing and able to comply with the study protocol requirements and all study-related visit requirements.
  • Female subjects at least 18 years old and capable of providing consent to participate.
  • Females of childbearing potential must have a negative urine pregnancy test within 36 hours prior to study drug administration and agree to use a medically accepted method of contraception for a period of one month following the study.

排除标准

  • Patients known to be pregnant or breast-feeding.
  • Patients with known or suspected iodine or ICG hypersensitivity.
  • Patients unable to remain stationary for one hour.
  • Active cellulitis.
  • Subjects with a preoperative clinical lymphedema diagnosis.
  • Subjects undergoing bilateral ALND.
  • Subjects requiring immediate chest wall reconstruction with a pedicled or microvascular flap, or those that have received preoperative radiation therapy.
  • Patients with BMI >45kg/m2.

研究组 & 干预措施

Postoperative Evaluations

Experimental

Participants who agree to take part in this study, clinic visit timing will be exactly the same time as would ordinarily be scheduled: before surgery, then 6, 12, 18, and 24 months after surgery. Each study visit should take about 2-3 hours.

干预措施: Immediate Lymphatic Reconstruction (ILR)/ (Procedure)

Postoperative Evaluations

Experimental

Participants who agree to take part in this study, clinic visit timing will be exactly the same time as would ordinarily be scheduled: before surgery, then 6, 12, 18, and 24 months after surgery. Each study visit should take about 2-3 hours.

干预措施: Prophylactic Lymphovenous Bypass (pLVB) (Procedure)

结局指标

主要结局

Freedom from lymphedema (FFL)

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验